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Parameter
All segments
N = 187
Change in SLV
Constriction Dilation
N = 78 N = 109 P-value
Baseline SLV
(mm3)
38.914.9 40.71.7 37.51.4 0.15
PAV (%) 40.212.0 42.51.4 38.61.1 0.029
EEM (mm3) 66.323.1 72.52.6 61.92.2 0.002
Necrotic (%) 16.410.3 18.31.2 14.90.98 0.029
Fibrotic (%) 73.513.4 71.01.6 75.61.3 0.026
Lipidic (%) 8.54.0 9.20.45 7.90.37 0.039
Calciﬁc (%) 1.51.8 1.50.21 1.580.18 0.72
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Sluminal area (MLA) 4mm2, non-calciﬁed VH-deﬁned thin cap ﬁbroatheroma
(ncVHTCFA)).
Results: 3,674mm of VH-IVUS pullback were studied. Stented plaque necrotic core
area was higher in ACS patients (25% [18-28] vs. 19% [14-26], p¼0.04). None of the
higher risk VH-IVUS features (PB70%, MLA4mm2, ncVHTCFA) were more
prevalent in ACS. Whole vessel and whole plaque Stress-P1 was similar between
groups. In contrast, Stress-P1 was increased in ACS patients where MLA4mm2
(8.24 [7.06-9.93] vs. 7.72 [6.33-9.34], p¼0.03), PB70% (9.18 [7.44-10.88] vs. 7.93
[6.16-9.46], p¼0.02) and ncVHTCFA (9.23 [7.33-11.44] vs. 7.65 [6.45-8.62],
p¼0.02), and markedly increased for combinations (e.g. MLA4mm2 and PB70%
(8.94 [7.23-10.70] vs. 7.74 [6.13-9.01] p¼0.009) and MLA4mm2 and ncVHTCFA
(8.73 [7.32-10.91] vs. 6.40 [5.83-7.53] p¼0.004)). There was a positive correlation
between increasing luminal area and Stress-P1 (r¼0.39, p<0.0001), but not with
plaque burden (r¼-0.03, p¼0.11). Stress-P1 increased the discriminatory power of
ncVHTCFA to predict ACS (area under the curve 0.558 vs. 0.717, p<0.0001).
Conclusions: Higher-risk plaque features deﬁned by VH-IVUS are associated with
increased maximum Stress-P1 in ACS patients. Elevated plaque stress may determine
whether a higher-risk plaque ruptures, and biomechanical modeling may increase the
ability of VH-IVUS to predict plaque rupture.
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Background: Intravascular ultrasound (IVUS) provides cross sectional imaging of
coronaries but lacks overview of the vascular territory provided by angiography. We
studied the feasibility of automated co-registration of angiography and IVUS to
facilitate interrogation of the two imaging modalities in a synchronous manner.
Methods: 49 consecutive patients undergoing surveillance for cardiac allograft vas-
culopathy with angiography and IVUS of the left anterior descending artery (LAD)
were enrolled. A pre-IVUS angiogram of the LAD was performed followed by an
ECG triggered ﬂuoroscopy (ECGTF) during IVUS pullback (Eagle Eye Platinum -
Volcano Corp.) at 0.5mm/s using an automatic pullback device. ECGTF was used to
track the IVUS catheter during pullback and establish a spatial relationship to the pre-
IVUS angiogram. Angio-IVUS co-registration was performed with a research proto-
type (Siemens Healthcare, Germany) and accuracy evaluated by distance mismatch
between angiography and IVUS images at vessel bifurcations (Figure A).
Results: The median (IQR) co-registration distance mismatch measured at 108
bifurcations in 42 (85%) patients was 0.35 (0.00-1.16) mm (Figure B). 7 patients were
excluded due to inappropriate data acquisition (n¼3) and failure of tracking (n¼4),
e.g. due to overlapping sternal wires. Estimated effective radiation dose for ECGTF
was 0.09mSv.
Conclusions: This study demonstrates the feasibility of angio-IVUS co-registration
which may be used as a clinical tool for localizing IVUS cross sections along an
angiographic roadmap.
Supporting File(s): Location: https://ww5.aievolution.com/tct2013/ﬁles/content/
abstracts/abs_1794/pic_for_pub.jpeg
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Background: Coronary atheroma composition and endothelial dysfunction are each
known to associate with incident coronary events, yet little is known about their
relationship in vivo. We tested the hypothesis that the degree of segmental epicardial
vasoreactivity relates to the composition of underlying atheroma.
Methods: In 23 NSTEMI patients referred for coronary angiography, a non-culprit
vessel underwent intracoronary salbutamol (0.30 mcg/min, 5 mins) provocation
during automated IVUS pullback. A 40 MHz IVUS catheter delivered radiofrequency
signals at constant 67micron intervals via a custom-built IVUS console (iMAP, iLAB,
Boston Scientiﬁc). Macrovascular response [change in segmental lumen volume
(SLV) at baseline and following salbutamol], percent atheroma volume (PAV) and
tissue composition was evaluated in 187 contiguous non-overlapping 5mm coronary
segments.
Results: Compared with segments that dilated (D in SLV >0), constrictive segments
(D in SLV 0) showed similar lumen, but greater vessel volumes and PAV at baseline
(Table). The extent of necrotic and lipidic plaque was signiﬁcantly greater in
constrictive segments, whereas ﬁbrotic plaque content was signiﬁcantly greater in
segments that dilated. Calciﬁc plaque content did not relate to endothelium-dependent
vasoreactivity. The change in SLV correlated inversely with the amount of lipidic and
necrotic plaque (both r ¼ -0.23, p¼0.002), and directly with ﬁbrotic plaque content
(r¼ 0.20, p¼0.009). In a multivariable model, the extent of both lipidic and necroticJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrplaque independently associated with segmental vasoconstriction (b ¼1.2, p¼0.023;
b ¼0.66, p¼0.027).
Conclusions: Following NSTEMI, both lipidic and necrotic plaque content each
associate with segmental endothelial dysfunction, providing a mechanistic link
between atheroma composition and lumen reactivity, and thus potential 'vulnerability'
for a clinical event.TCT-649
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Background: Visit-to-visit variability in systolic blood pressure (SBP) was reported
to be associated with increased cardiovascular risk. Intravascular ultrasound (IVUS) is
used as an end point in studies aimed at reducing progression or regression of coro-
nary atheroma. However, the relationship between variability in blood pressure and
atheroma volume changes by IVUS, or long-term clinical outcomes has been poorly
deﬁned.
Methods: Serial IVUS examinations were performed in 338 stable angina pectoris
patients undergoing percutaneous coronary intervention (PCI). After PCI for culprit
lesions, intravascular ultrasound (IVUS) was performed in their non-culprit vessels to
determine atheroma volume at baseline. After 12-16 months, IVUS of the originally
examined coronary artery was performed during follow-up angiography. Five-year
clinical outcomes, including major adverse cardio- and cerebrovascular events
(MACCE), and annual progression rate of atherosclerosis by volumetric IVUS, and
visit-to-visit variability in SBP for ﬁve-years were evaluated.
Results: Atheroma volume increase by IVUS was 5.7%, and ﬁve-years MACCE rate
was 22.6%. Patients with MACCE had larger annual atheroma progression than the
rest of the population (20.6% vs. 2.3%, P<0.001). Visit-to-visit variability in SBP was
a strong predictor of subsequent increased coronary atheroma volume (eg., top-decile
hazard ratio (HR) for SD SBP over ﬁve visits: 4.18, 95% CI 1.95–6.87, p<0.01),
independent of mean SBP, but dependent on precision of measurement (top-decile HR
over ﬁve visits: 4.21, 2.58–7.64, p<0.01). Maximum SBP reached was also a strong
predictor of MACCE (HR for top- decile over ﬁve visits: 8.12, 3.46–10.11, p<0.01,
after adjustment for mean SBP). In addition, residual visit-to-visit variability in SBP
on treatment was also a strong predictor of increased coronary atheroma volume and
MACCE (top-decile HR for MACCE: 4.49, 1.92–6.48, p<0.01).
Conclusions: Visit-to-visit variability in SBP and maximum SBP are strong predictors
of increased coronary atheroma volume, independent of mean SBP. Increased residual
variability in SBP in patients with treated hypertension is associated with a high risk of
subsequent cardiovascular events.
TCT-650
The high sensitive C-reactive protein (hs-CRP) level represents the disease
burden and the age but not vulnerability of coronary atherosclerosis: a study of
volumetric plaque composition by 3-vessel virtual histology-intravascular
ultrasound
Se-Jun Park1, So-Yeon Choi1, You-Hong Lee1, Yong-Woo Choi1, Jeoung-sook Shin1,
Kyoung-Woo Seo1, Jin-Sun Park1, Hyoung-Mo Yang1, Hong-Seok Lim2,
Byoung-Joo Choi1, Gyo-Seung Hwang1, Seung-Jea Tahk1
1Ajou University School of Medicine, Suwon, Korea, Republic of, 2Stanford University
Medical Center, Stanford, CA
Background: hs-CRP has been known as a systemic inﬂammatory marker of
atherosclerosis and considered as one of the predictors of future cardiac events. Some
reports presented hs-CRP level was associated with plaque vulnerability but most
studies were performed by assessing focal target plaque but not whole plaques from
a coronary tree.
Methods: To evaluate of the relationship of plasma hs-CRP level and volumetric
plaque composition of the coronary arterial tree, we performed 'whole vessel" virtual
histology-intravascular ultrasound (VH-IVUS) in 189 vessels of 63 patients.The
components of atherosclerosis were classiﬁed as ﬁbrous (FI), ﬁbrous-fatty (FF),acts/POSTER/Intravascular Imaging and Coronary Artery Disease B197
